These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 37326116)

  • 41. Imaging in Parkinson's disease.
    Pagano G; Niccolini F; Politis M
    Clin Med (Lond); 2016 Aug; 16(4):371-5. PubMed ID: 27481384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Engaging cognitive circuits to promote motor recovery in degenerative disorders. exercise as a learning modality.
    Jakowec MW; Wang Z; Holschneider D; Beeler J; Petzinger GM
    J Hum Kinet; 2016 Sep; 52():35-51. PubMed ID: 28149392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
    Boertien JM; van der Zee S; Chrysou A; Gerritsen MJJ; Jansonius NM; Spikman JM; van Laar T;
    BMC Neurol; 2020 Jun; 20(1):245. PubMed ID: 32534583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytokine-, Neurotrophin-, and Motor Rehabilitation-Induced Plasticity in Parkinson's Disease.
    Policastro G; Brunelli M; Tinazzi M; Chiamulera C; Emerich DF; Paolone G
    Neural Plast; 2020; 2020():8814028. PubMed ID: 33293946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of lifelong cognitive lifestyle on executive function in older people with Parkinson's disease.
    Hindle JV; Martin-Forbes PA; Martyr A; Bastable AJM; Pye KL; Mueller Gathercole VC; Thomas EM; Clare L
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):e157-e165. PubMed ID: 28170111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease.
    Kip E; Parr-Brownlie LC
    Ageing Res Rev; 2022 Jun; 78():101618. PubMed ID: 35395416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lifestyle-dependent microglial plasticity: training the brain guardians.
    Augusto-Oliveira M; Verkhratsky A
    Biol Direct; 2021 Aug; 16(1):12. PubMed ID: 34353376
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can neuroimaging predict dementia in Parkinson's disease?
    Lanskey JH; McColgan P; Schrag AE; Acosta-Cabronero J; Rees G; Morris HR; Weil RS
    Brain; 2018 Sep; 141(9):2545-2560. PubMed ID: 30137209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroimaging and serum biomarkers of neurodegeneration and neuroplasticity in Parkinson's disease patients treated by intermittent theta-burst stimulation over the bilateral primary motor area: a randomized, double-blind, sham-controlled, crossover trial study.
    Rashid-López R; Macías-García P; Sánchez-Fernández FL; Cano-Cano F; Sarrias-Arrabal E; Sanmartino F; Méndez-Bértolo C; Lozano-Soto E; Gutiérrez-Cortés R; González-Moraleda Á; Forero L; López-Sosa F; Zuazo A; Gómez-Molinero R; Gómez-Ramírez J; Paz-Expósito J; Rubio-Esteban G; Espinosa-Rosso R; Cruz-Gómez ÁJ; González-Rosa JJ
    Front Aging Neurosci; 2023; 15():1258315. PubMed ID: 37869372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease.
    Palasz E; Niewiadomski W; Gasiorowska A; Wysocka A; Stepniewska A; Niewiadomska G
    Front Neurol; 2019; 10():1143. PubMed ID: 31736859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?
    Belvisi D; Pellicciari R; Fabbrini G; Tinazzi M; Berardelli A; Defazio G
    Neurobiol Dis; 2020 Feb; 134():104671. PubMed ID: 31706021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Imaging behavioural complications of Parkinson's disease.
    Valli M; Mihaescu A; Strafella AP
    Brain Imaging Behav; 2019 Apr; 13(2):323-332. PubMed ID: 28856542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson's disease.
    Martínez-Horta S; Bejr-Kasem H; Horta-Barba A; Pascual-Sedano B; Santos-García D; de Deus-Fonticoba T; Jesús S; Aguilar M; Planellas L; García-Caldentey J; Caballol N; Vives-Pastor B; Hernández-Vara J; Cabo-Lopez I; López-Manzanares L; González-Aramburu I; Ávila-Rivera MA; Catalán MJ; López-Díaz LM; Puente V; García-Moreno JM; Borrué C; Solano-Vila B; Álvarez-Sauco M; Vela L; Escalante S; Cubo E; Carrillo-Padilla F; Martínez-Castrillo JC; Sánchez-Alonso P; Alonso-Losada MG; López-Ariztegui N; Gastón I; Blázquez-Estrada M; Seijo-Martínez M; Rúiz-Martínez J; Valero-Merino C; Kurtis M; de Fábregues-Boixar O; González-Ardura J; Prieto-Jurczynska C; Martinez-Martin P; Mir P; Kulisevsky J;
    BMC Neurol; 2021 Dec; 21(1):477. PubMed ID: 34879838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroimaging advances in Parkinson's disease.
    Rispoli V; Schreglmann SR; Bhatia KP
    Curr Opin Neurol; 2018 Aug; 31(4):415-424. PubMed ID: 29878908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Future of Brain Imaging in Parkinson's Disease.
    Helmich RC; Vaillancourt DE; Brooks DJ
    J Parkinsons Dis; 2018; 8(s1):S47-S51. PubMed ID: 30584163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson's disease.
    Petzinger GM; Fisher BE; Van Leeuwen JE; Vukovic M; Akopian G; Meshul CK; Holschneider DP; Nacca A; Walsh JP; Jakowec MW
    Mov Disord; 2010; 25 Suppl 1(0 1):S141-5. PubMed ID: 20187247
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A divergent breakdown of neurocognitive networks in Parkinson's Disease mild cognitive impairment.
    Aracil-Bolaños I; Sampedro F; Marín-Lahoz J; Horta-Barba A; Martínez-Horta S; Botí M; Pérez-Pérez J; Bejr-Kasem H; Pascual-Sedano B; Campolongo A; Izquierdo C; Gironell A; Gómez-Ansón B; Kulisevsky J; Pagonabarraga J
    Hum Brain Mapp; 2019 Aug; 40(11):3233-3242. PubMed ID: 30938027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serotonergic imaging in Parkinson's disease.
    de Natale ER; Wilson H; Politis M
    Prog Brain Res; 2021; 261():303-338. PubMed ID: 33785134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lifestyle changes for treating psoriasis.
    Ko SH; Chi CC; Yeh ML; Wang SH; Tsai YS; Hsu MY
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011972. PubMed ID: 31309536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.